![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Injection Site Reactions with Subcutaneous Lenacapavir
Administration at Alternate Injection Sites
|
|
|
25th International AIDS Conference (AIDS 2024); July 22–26, 2024; Munich, Germany
Gary Saunders1*, Eva Mortensen2, Gong Shen2, Aryun Kim2
1Gilead Sciences, Inc., Cambridge, United Kingdom; 2Gilead Sciences, Inc., Foster City, California, United States
*Presenting author
![0730241](../images/073024/073024-4/0730241.gif)
![0730242](../images/073024/073024-4/0730242.gif)
![0730243](../images/073024/073024-4/0730243.gif)
![0730244](../images/073024/073024-4/0730244.gif)
![0730245](../images/073024/073024-4/0730245.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|